{ "module": "kr-companies", "itemId": "00116824", "title": "Dong-A Pharmaceutical Co.,Ltd. (동아제약(주)) — KOSPI 000640", "summary": "Korean listed company (동아제약(주), KOSPI 000640). Official DART corporate profile, KRW financial summary, and recent filings.", "data": { "corp_code": "00116824", "stock_code": "000640", "name_en": "Dong-A Pharmaceutical Co.,Ltd.", "name_ko": "동아제약(주)", "alternate_names": [ "동아제약" ], "market": "KOSPI", "ceo_name": "김민영", "business_registration_no": "2048100130", "corporate_registration_no": "1101110017990", "address": "서울특별시 동대문구 천호대로 64", "homepage": "https://www.donga.co.kr/", "established_date": "1949-08-09", "fiscal_month": "12", "industry_code": "64992", "financials": { "fiscal_year": 2025, "basis": "CFS", "currency": "KRW", "revenue": 1429766810735, "operating_income": 97772974663, "net_income": 91466489869, "total_assets": 2079304723754, "total_liabilities": 927773911607, "total_equity": 1151530812147, "prior_year": { "fiscal_year": 2024, "revenue": 1333229636666, "operating_income": 82094664924, "net_income": 57573399359, "total_assets": 2030483787016, "total_liabilities": 966546316740, "total_equity": 1063937470276 }, "source_url": "https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260318001307", "verified_at": "2026-11-01T02:28:09.811Z" }, "recent_filings": [ { "receipt_no": "20261030800944", "filed_date": "2026-10-30", "title_ko": "투자판단관련주요경영사항(자회사의 주요경영사항) (제2형 당뇨병 치료 복합제 슈가엠파정 국내 품목허가 승인)", "title_en": "Material Business Matters Related to Investment Decisions(Subsidiary's material business matters) (제2형 당뇨병 치료 복합제 슈가엠파정 국내 품목허가 승인)", "filer": "동아제약", "url": "https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20261030800944" }, { "receipt_no": "20261027800214", "filed_date": "2026-10-27", "title_ko": "기업설명회(IR)개최(안내공시)", "title_en": "Organization of Investor Relations Event", "filer": "동아제약", "url": "https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20261027800214" }, { "receipt_no": "20261027800177", "filed_date": "2026-10-27", "title_ko": "연결재무제표기준영업(잠정)실적(공정공시)", "title_en": "Report on Business Performance according to Consolidated Financial Statements (Fair Disclosure)", "filer": "동아제약", "url": "https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20261027800177" }, { "receipt_no": "20261022800425", "filed_date": "2026-10-22", "title_ko": "기업설명회(IR)개최(안내공시)", "title_en": "Organization of Investor Relations Event", "filer": "동아제약", "url": "https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20261022800425" }, { "receipt_no": "20261022800420", "filed_date": "2026-10-22", "title_ko": "결산실적공시예고(안내공시)", "title_en": "Prior Notice on Disclosure of Final Earnings", "filer": "동아제약", "url": "https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20261022800420" }, { "receipt_no": "20261016800364", "filed_date": "2026-10-16", "title_ko": "단일판매ㆍ공급계약체결(자회사의 주요경영사항)", "title_en": "Conclusion of Single Sales Contract or Supply Contract(Subsidiary's material business matters)", "filer": "동아제약", "url": "https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20261016800364" }, { "receipt_no": "20261008000287", "filed_date": "2026-10-08", "title_ko": "임원ㆍ주요주주특정증권등소유상황보고서", "title_en": "Report on status of specific securities, etc. owned by executives and major shareholders", "filer": "홍민아", "url": "https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20261008000287" }, { "receipt_no": "20261008000284", "filed_date": "2026-10-08", "title_ko": "임원ㆍ주요주주특정증권등소유상황보고서", "title_en": "Report on status of specific securities, etc. owned by executives and major shareholders", "filer": "조진욱", "url": "https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20261008000284" }, { "receipt_no": "20261008000283", "filed_date": "2026-10-08", "title_ko": "임원ㆍ주요주주특정증권등소유상황보고서", "title_en": "Report on status of specific securities, etc. owned by executives and major shareholders", "filer": "정민", "url": "https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20261008000283" }, { "receipt_no": "20261008000276", "filed_date": "2026-10-08", "title_ko": "임원ㆍ주요주주특정증권등소유상황보고서", "title_en": "Report on status of specific securities, etc. owned by executives and major shareholders", "filer": "이남용", "url": "https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20261008000276" }, { "receipt_no": "20261008000275", "filed_date": "2026-10-08", "title_ko": "임원ㆍ주요주주특정증권등소유상황보고서", "title_en": "Report on status of specific securities, etc. owned by executives and major shareholders", "filer": "윤춘희", "url": "https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20261008000275" }, { "receipt_no": "20261008000270", "filed_date": "2026-10-08", "title_ko": "임원ㆍ주요주주특정증권등소유상황보고서", "title_en": "Report on status of specific securities, etc. owned by executives and major shareholders", "filer": "신남수", "url": "https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20261008000270" }, { "receipt_no": "20261008000269", "filed_date": "2026-10-08", "title_ko": "임원ㆍ주요주주특정증권등소유상황보고서", "title_en": "Report on status of specific securities, etc. owned by executives and major shareholders", "filer": "송인식", "url": "https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20261008000269" }, { "receipt_no": "20261008000268", "filed_date": "2026-10-08", "title_ko": "임원ㆍ주요주주특정증권등소유상황보고서", "title_en": "Report on status of specific securities, etc. owned by executives and major shareholders", "filer": "차태웅", "url": "https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20261008000268" }, { "receipt_no": "20261008000266", "filed_date": "2026-10-08", "title_ko": "임원ㆍ주요주주특정증권등소유상황보고서", "title_en": "Report on status of specific securities, etc. owned by executives and major shareholders", "filer": "오종원", "url": "https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20261008000266" }, { "receipt_no": "20261008000263", "filed_date": "2026-10-08", "title_ko": "임원ㆍ주요주주특정증권등소유상황보고서", "title_en": "Report on status of specific securities, etc. owned by executives and major shareholders", "filer": "김용운", "url": "https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20261008000263" }, { "receipt_no": "20261008000260", "filed_date": "2026-10-08", "title_ko": "임원ㆍ주요주주특정증권등소유상황보고서", "title_en": "Report on status of specific securities, etc. owned by executives and major shareholders", "filer": "강보성", "url": "https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20261008000260" }, { "receipt_no": "20261008000256", "filed_date": "2026-10-08", "title_ko": "임원ㆍ주요주주특정증권등소유상황보고서", "title_en": "Report on status of specific securities, etc. owned by executives and major shareholders", "filer": "백상환", "url": "https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20261008000256" }, { "receipt_no": "20261008800299", "filed_date": "2026-10-08", "title_ko": "최대주주등소유주식변동신고서", "title_en": "Report on Shares Change of Largest Shareholders", "filer": "동아제약", "url": "https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20261008800299" }, { "receipt_no": "20261002800881", "filed_date": "2026-10-02", "title_ko": "지주회사의자회사편입", "title_en": "Inclusion of Subsidiary in Holding Company", "filer": "동아제약", "url": "https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20261002800881" } ], "source_urls": { "company": "https://dart.fss.or.kr", "financials": "https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260318001307", "filings": "https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20261030800944" }, "source_url": "https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260318001307", "verified_at": "2026-11-01T02:16:03.464Z", "notice": "Data from Korea's Financial Supervisory Service (DART) and National Tax Service. FSS does not guarantee accuracy or completeness. Figures in KRW as filed. Not investment advice. English names are as registered with DART and may differ from the Korean legal name. Use corp_code, stock_code, or business registration number to identify a company." }, "source_url": "https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260318001307", "verified_at": "2026-11-01T02:16:03.464Z", "updated_at": "2026-11-01T02:16:03.464Z", "notice": "Data from Korea's Financial Supervisory Service (DART) and National Tax Service. FSS does not guarantee accuracy or completeness. Figures in KRW as filed. Not investment advice. English names are as registered with DART and may differ from the Korean legal name. Use corp_code, stock_code, or business registration number to identify a company." }